Cannabis Investment Report |

December 2017

Representative Dosage Amounts

Desired Effect or Ailment Dosage
“High” 10 mg THC
Anxiety, depression, spasms 25 mg CBD
Cancer 25 mg CBD
Chronic pain 2.5-20 mg THC
Epileptic seizures 200-300 mg CBD
Glaucoma 20-40 mg CBD
Increased appetite 2.5 mg THC

Multiple sclerosis 2.5-120 mg THC
40-1,280 mg CBD

40-160 mg CBD

Schizophrenia
Sleep disorders

Neither the potential medicinal benefits and therapeutic

Dosage Ratio
(THC:CBD)

10:1 to 100:1
1:10
1:1
10:1
1:5
1:2 to 1:4
5:1
1:1
1:4 to 1:128
1:4 to 1:16

applications of cannabis consumption nor

the negative side effects of cannabis use have been thoroughly researched by medical science. Short-

term negative side effects are believed by some to include sensory distortion, panic, anxiety, poor coor-

dination of movement, reduced reaction time, lethargy or drowsiness, depression and elevated heart

rate. Longer-term effects may include suppression of the immune system, growth disorders, destruc-

tion of lung fibers, brain lesions, reduced sexual capacity, difficulties with concentration, reduced abil-

ity to learn and retain information, and personality and moo
about whether cannabis consumption may lead to the abuse
“gateway drug” debate).

30

d changes. There is also an ongoing debate
of more harmful substances (the so-called

© 2017 Ackrell Capital, LLC | Member FINRA/SIPC

HOUSE_OVERSIGHT_024666
